BIOTECHNOLOGY ULTRASECTOR PROFUND is a registered fund series of ProFunds (series S000003107). Net assets $182.6M as of 2026-04-30. Index fund.
Showing 15 of 157 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| HSBC SECURITIES (USA), INC. B 3.5 , 5/01/2026 | — | $15.5M | 847.35% |
| SOCIETE' GENERALE 3.52 , 5/01/2026 | — | $13.2M | 720.23% |
| CF Secured 3.52 , 5/01/2026 | — | $11.6M | 635.50% |
| NATWEST MARKETS PLC 3.51 , 5/01/2026 | — | $7.7M | 423.65% |
| UMB FINANCIAL CORP. 3.37 , 5/01/2026 | — | $3.8M | 210.70% |
| AGPXX | — | $3.7M | 205.19% |
| ROYAL BANK OF CANADA 3.42 , 5/01/2026 | — | $2.7M | 148.26% |
| APELLIS PHARMACEUTICALS INC | — | $2.5M | 134.83% |
| REVOLUTION MEDICINES INC | — | $2.2M | 119.09% |
| TRAVERE THERAPEUTICS INC | — | $2.1M | 117.14% |
| ARROWHEAD PHARMACEUTICALS INC | — | $1.9M | 104.07% |
| TWIST BIOSCIENCE CORP | — | $1.9M | 102.64% |
| SUMMIT THERAPEUTICS INC | — | $1.9M | 101.44% |
| ALKERMES PLC | — | $1.8M | 99.89% |
| TG THERAPEUTICS INC | — | $1.8M | 99.10% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $182.6M |
| 2026-01-31 | $177.4M |
| 2025-10-31 | $87.6M |
| 2025-07-31 | $62.8M |
| 2025-04-30 | $66.2M |
| 2025-01-31 | $84.9M |
| 2024-10-31 | $100.5M |
| 2024-07-31 | $108.8M |